Access cutting-edge graft-versus-host disease treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access graft-versus-host disease specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related graft-versus-host disease treatment provided free
The purpose of this study is to find out whether adding belumosudil to a usual approach for reducing the risk of graft-versus-host disease (GVHD) may be an effective GVHD prevention approach for people with blood cancer who have a stem cell transplant. The investigators will also look at the safety of the study approach.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this graft-versus-host disease clinical trial in New York, NY
If you're searching for graft-versus-host disease treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced graft-versus-host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.